Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 6 '25)

Image
By G.M.

 


    Antiviral Res

  1. MAIA AR, Gonzalez L, Bounab B, Grassi L, et al
    Intranasal exposure to commensal bacterium Rothia mucilaginosa protects against influenza A virus infection.
    Antiviral Res. 2025 Jan 2:106076. doi: 10.1016/j.antiviral.2025.106076.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  2. CULIAT C, Soni D, Malkes W, Wienhold M, et al
    NELL1 variant protein (NV1) modulates hyper-inflammation, Th-1 mediated immune response, and the HIF-1alpha hypoxia pathway to promote healing in viral-induced lung injury.
    Biochem Biophys Res Commun. 2025;744:151198.
    PubMed         Abstract available


    Cell

  3. PASQUESI GIM, Allen H, Ivancevic A, Barbachano-Guerrero A, et al
    Regulation of human interferon signaling by transposon exonization.
    Cell. 2024;187:7621-7636.
    PubMed         Abstract available


    J Neurosurg Pediatr

  4. LUNDY P, Barkley A, Rahman AKMF, Arynchyna-Smith A, et al
    Pediatric CSF diversion procedures for treatment of hydrocephalus during the COVID-19 pandemic.
    J Neurosurg Pediatr. 2024;35:57-63.
    PubMed         Abstract available


    N Engl J Med

  5. GARG S, Reinhart K, Couture A, Kniss K, et al
    Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.
    N Engl J Med. 2024 Dec 31. doi: 10.1056/NEJMoa2414610.
    PubMed         Abstract available

  6. JASSEM AN, Roberts A, Tyson J, Zlosnik JEA, et al
    Critical Illness in an Adolescent with Influenza A(H5N1) Virus Infection.
    N Engl J Med. 2024 Dec 31. doi: 10.1056/NEJMc2415890.
    PubMed        


    Pediatrics

  7. LOPEZ-LACORT M, Munoz-Quiles C, Mira-Iglesias A, Xavier Lopez-Labrador F, et al
    Nirsevimab Effectiveness Against Severe Respiratory Syncytial Virus Infection in the Primary Care Setting.
    Pediatrics. 2025;155:e2024066393.
    PubMed         Abstract available


    PLoS One

  8. LACKNER M, Sunde U, Winter-Ebmer R
    The forces behind social unrest: Evidence from the Covid-19 pandemic.
    PLoS One. 2025;20:e0314165.
    PubMed         Abstract available

  9. HAMJA MA, Hasan M, Rashid MA, Shourov MTH, et al
    Exploring happiness factors with explainable ensemble learning in a global pandemic.
    PLoS One. 2025;20:e0313276.
    PubMed         Abstract available

  10. LEE SH, Kastor W, Fu X, Soni V, et al
    Development and application of decontamination methods for the re-use of laboratory grade plastic pipette tips.
    PLoS One. 2024;19:e0301950.
    PubMed         Abstract available

  11. GYAMERAH AO, Dunham AE, Ikeda J, Canizares AC, et al
    Impact of the COVID-19 pandemic on violence exposure and alcohol use among adults who drink alcohol.
    PLoS One. 2024;19:e0316096.
    PubMed         Abstract available

  12. WIJNBERG ID, Soons AJ, Reimerink JG, Wiersma M, et al
    The performance of a lateral flow SARS-CoV-2 antibody assay and semi-autonomous SARS-CoV-2 antisense and sense RNA fluorescence in situ hybridization assay in a prospective cohort pilot study within a Dutch military population.
    PLoS One. 2024;19:e0309091.
    PubMed         Abstract available

  13. HOLLISTER J, Porter C, Sprissler R, Beitel SC, et al
    Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance.
    PLoS One. 2024;19:e0306953.
    PubMed         Abstract available

  14. CHO S, Hisamitsu S, Jin H, Toyoda M, et al
    Analyzing information sharing behaviors during stance formation on COVID-19 vaccination among Japanese Twitter users.
    PLoS One. 2024;19:e0299935.
    PubMed         Abstract available

  15. BRINKMANN M, Stolz M, Herr A, Herrmann-Lingen C, et al
    Care for post-COVID-19 condition in Germany from the perspectives of patients, informal caregivers and general practitioners: Study protocol for a mixed methods study.
    PLoS One. 2024;19:e0316335.
    PubMed         Abstract available

  16. HONGJAISEE S, Khamduang W, Kham-Kjing N, Ngo-Giang-Huong N, et al
    Seroprevalence and associated factors of HIV, syphilis, hepatitis B, and hepatitis C infections among sex workers in Chiangmai, Thailand during easing of COVID-19 lockdown measures.
    PLoS One. 2024;19:e0316668.
    PubMed         Abstract available

  17. MARKIEWICZ K, Kaczmarek BLJ
    Implemental delay as a mediator of the relationship between depression, anxiety, stress and school burnout.
    PLoS One. 2024;19:e0316082.
    PubMed         Abstract available

  18. BELO AVM, Prasetyo YT, Roque RAC, Benito OP, et al
    Investigating students' intention to utilize an e-learning platform in an aviation institution during the COVID-19 pandemic.
    PLoS One. 2024;19:e0308180.
    PubMed         Abstract available

  19. SATHANAPALLY H, Chudasama YV, Zaccardi F, Rizzi A, et al
    Health outcome priorities of people with multiple long-term conditions using the outcome prioritisation tool in the UK: A survey study and feasibility assessment.
    PLoS One. 2024;19:e0301740.
    PubMed         Abstract available

  20. HASSAN MZ, Basher AK, Rahman MZ, Bhuiyan TR, et al
    Study protocol for COVID-19 breakthrough infections and vaccine-induced immune response among a cohort of healthcare workers, Bangladesh.
    PLoS One. 2024;19:e0316121.
    PubMed         Abstract available

  21. FAHMI A, Palin V, Zhong X, Yang YT, et al
    Evaluation of the impact of COVID-19 pandemic on hospital admission related to common infections: Risk prediction models to tackle antimicrobial resistance in primary care.
    PLoS One. 2024;19:e0311515.
    PubMed         Abstract available

  22. WEGAYEHU T, Yohannes T, Churko C, Bekele A, et al
    Adherence to implementing physical distancing and other COVID-19 preventive measures and its barriers among adults in Arba Minch town, Southwest Ethiopia: A lesson learned from the pandemic.
    PLoS One. 2024;19:e0315204.
    PubMed         Abstract available

  23. JAROENPOOL J, Maneerattanasak S, Adesina F, Phumee A, et al
    A primary school-based dengue solution model for post-COVID-19 in southern Thailand: Students understanding of the dengue solution and larval indices surveillance system.
    PLoS One. 2024;19:e0313171.
    PubMed         Abstract available

  24. BROCKE SA, Reidel B, Ehre C, Rebuli ME, et al
    Profiling endogenous airway proteases and antiproteases and modeling proteolytic activation of Influenza HA using in vitro and ex vivo human airway surface liquid samples.
    PLoS One. 2024;19:e0306197.
    PubMed         Abstract available

  25. IMRAN MTI, Karmaker CL, Karim R, Misbauddin SM, et al
    Modeling the supply chain sustainability imperatives in the fashion retail industry: Implications for sustainable development.
    PLoS One. 2024;19:e0312671.
    PubMed         Abstract available

  26. FACHIROH J, Lestari SK, Paramita DK, Bintoro BS, et al
    Seroconversion and dynamics of IgG anti-SARS-CoV-2 antibodies during the pandemic: A two-month observation cohort study on the population of Sleman in Indonesia.
    PLoS One. 2025;20:e0316360.
    PubMed         Abstract available

  27. LOMBARD B, Cohen C, von Gottberg A, Dushoff J, et al
    A generalised catalytic model to assess changes in risk for multiple reinfections with SARS-CoV-2.
    PLoS One. 2025;20:e0315476.
    PubMed         Abstract available

  28. ALGHAMDI AS, Alnaji L
    A new extended Chen distribution for modelling COVID-19 data.
    PLoS One. 2025;20:e0316235.
    PubMed         Abstract available

  29. ABDEL-QADER DH, Abdel-Qader H, Silverthorne J, Kongkaew C, et al
    Investigating the point prevalence, types, severity, causes and predictors of vaccines administration errors during COVID-19 pandemic in Jordan.
    PLoS One. 2025;20:e0312050.
    PubMed         Abstract available

  30. MOZNER O, Szabo E, Kulin A, Varady G, et al
    Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity.
    PLoS One. 2025;20:e0316396.
    PubMed         Abstract available

  31. PATZINA A, Collischon M, Hoffmann R, Obrizan M, et al
    Mental health in Germany before, during and after the COVID-19 pandemic.
    PLoS One. 2025;20:e0313689.
    PubMed         Abstract available

  32. BERMUDEZ-ABREUT E, Fundora-Barrios T, Hernandez Fernandez DR, Noa Romero E, et al
    Antiviral activity of an ACE2-Fc fusion protein against SARS-CoV-2 and its variants.
    PLoS One. 2025;20:e0312402.
    PubMed         Abstract available

  33. UBEDA M, Villa-Cordero V, Gonzalez-Rodriguez A, Andres-Cabello S, et al
    Lessons learned from cross-sectoral collaboration to protect migrant farmworkers during COVID-19 in Spain.
    PLoS One. 2025;20:e0307578.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  34. MAZIGI O, Langley DB, Henry JY, Burnett DL, et al
    Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2025;122:e2417544121.
    PubMed         Abstract available


    Vaccine

  35. AI L, Gao Z, Lv H, Zhang J, et al
    Immunogenicity and safety of live attenuated influenza vaccine in children aged 3-17 years in China.
    Vaccine. 2024;46:126653.
    PubMed         Abstract available

  36. HAEBERER M, Lopez-Ibanez de Aldecoa A, Seabroke S, Ramirez Agudelo JL, et al
    Hospitalization cost estimates of respiratory syncytial virus and influenza infections in adults in Spain, 2016-2019.
    Vaccine. 2024;46:126683.
    PubMed         Abstract available

  37. MA Y, Dong C, Kim JK, Zhu W, et al
    Impact of influenza immune imprinting on immune responses to subsequent vaccinations in mice.
    Vaccine. 2024;46:126670.
    PubMed         Abstract available

  38. ZHANG J, Zhang L, Li J, Ma J, et al
    Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season.
    Vaccine. 2024;46:126662.
    PubMed         Abstract available

  39. MALTEZOU HC, Poland GA, de Lejarazu RO
    Influenza vaccination for children in Europe: The health of every child matters.
    Vaccine. 2024 Dec 27:126675. doi: 10.1016/j.vaccine.2024.126675.
    PubMed        

  40. CHOI YJ, Jung J, Kang M, Choi MJ, et al
    Corrigendum to The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: propensity score-matched analysis with influenza vaccination.
    Vaccine. 2024;46:126676.
    PubMed        

  41. PILAPITIYA D, Lee WS, Vu MN, Kelly A, et al
    Mucosal vaccination against SARS-CoV-2 using recombinant influenza viruses delivering self-assembling nanoparticles.
    Vaccine. 2024;46:126668.
    PubMed         Abstract available

  42. ANSELEM O, Charlier C, Viaud M, Lelong N, et al
    Barriers to influenza vaccination during pregnancy in France: A national population-based study.
    Vaccine. 2025;47:126671.
    PubMed         Abstract available

  43. ALVARADO-FACUNDO E, Herrup R, Wang W, Colombo RE, et al
    Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines.
    Vaccine. 2025;46:126669.
    PubMed         Abstract available


    Virology

  44. MCKENNA S, Jung KI, Wolf JJ, Seo YJ, et al
    Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication.
    Virology. 2024;603:110367.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#USA, Two more #human cases of #H5N1 #birdflu reported in #California

By G.M.
Two cases of bird flu have been reported in San Joaquin County, California, local health officials said. According to a press release issued Friday and reported by the Sacramento Bee , health officials with San Joaquin County Public Health Services said both cases were farm workers who were exposed to infected animals . Both people are showing mild symptoms and are recovering, officials said, adding that there are 34 total confirmed cases across California. In a warning posted on Facebook, health officials said bird flu was “spreading in several farms such as poultry and cattle” and urged residents to take precautions to prevent the spread of the disease. Precautions include the use of protective equipment when handling poultry, dairy cattle or other animals that may be infected, and when handling raw and unpasteurized milk. (...) There are currently 60 confirmed cases of bird flu in the country . While most of the cases are in California , other states with confirmed cases include Col...
Post a Comment
Read more »

Viral #sepsis: #diagnosis, clinical #features, #pathogenesis, and #clinical considerations

By G.M.
Abstract Sepsis , characterized as life-threatening organ dysfunction resulting from dysregulated host responses to infection , remains a significant challenge in clinical practice . Despite advancements in understanding host-bacterial interactions , molecular responses, and therapeutic approaches, the mortality rate associated with sepsis has consistently ranged between 10 and 16%. This elevated mortality highlights critical gaps in our comprehension of sepsis etiology. Traditionally linked to bacterial and fungal pathogens, recent outbreaks of acute viral infections , including Middle East respiratory syndrome coronavirus ( MERS-CoV ), influenza virus, and severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), among other regional epidemics, have underscored the role of viral pathogenesis in sepsis, particularly when critically ill patients exhibit classic symptoms indicative of sepsis. However, many cases of viral-induced sepsis are frequently underdiagnosed because standar...
Post a Comment
Read more »

Rapid #Surge of #Reassortant A(#H1N1) #Influenza Viruses in Danish #Swine and their #Zoonotic Potential

By G.M.
 Source: BioRxIV, https://www.biorxiv.org/content/10.1101/2024.12.11.627926v1?rss=1  Abstract In 2018, a single detection of a novel reassortant swine influenza A virus (swIAV) was made in Denmark . The hemagglutinin (HA) of the virus was from the H1N1 pandemic 2009 (H1N1pdm09) lineage and the neuraminidase (NA) from the H1N1 Eurasian avian-like swine lineage (H1N1av). By 2022, the novel reassortant virus (H1pdm09N1av) constituted 27 % of swIAVs identified through the Danish passive swIAV surveillance program. Sequencing detected two H1pdm09N1av genotypes ; Genotype 1 contained an internal gene cassette of H1N1pdm09 origin , Genotype 2 differed by carrying an NS gene segment of H1N1av origin . The internal gene cassette of Genotype 2 became increasingly dominant, not only in the H1pdm09N1av population, but also in other Danish enzootic swIAV subtypes . Phylogenetic analysis of the HA genes from H1pdm09N1av viruses revealed a monophyletic source , a higher substitution rat...
Post a Comment
Read more »